G9560 HCPCS — Reimbursement & Policy Benchmarks

Headline: HCPCS Level II code G9560 denotes omission of beta-lactam definitive therapy with no reason recorded

Lead: HCPCS Level II code G9560 captures instances where a patient was not provided a beta-lactam antibiotic as definitive therapy and no documented reason is given. The code supports documentation of antimicrobial management choices and has implications for stewardship reporting, clinical review, and payer adjudication.

What the code represents and why it matters: G9560 documents a specific antibiotic decision — omission of a beta-lactam agent without recorded rationale. Nationally, consistent use of such codes contributes to clearer records of treatment decisions, aids quality monitoring for antimicrobial stewardship, and may affect payer review of treatment appropriateness.

Key payers covered: Analysis typically examines coverage and claims handling across major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

What readers will learn: The publication provides benchmarks for use and documentation of G9560, summarizes payer considerations, explains clinical context for non–beta-lactam definitive therapy, and outlines common modifiers and coding practice issues. It flags areas where documentation gaps (reason not given) may prompt clinical or administrative follow-up.

Scope: This is a national overview focused on billing, documentation, and clinical-context implications for G9560. Data not available in the input.

Billing Code Overview

HCPCS Level II code G9560 indicates that a patient was not treated with a beta-lactam antibiotic as definitive therapy, with the reason not given. This code is used to document antimicrobial management decisions when a beta-lactam agent is not selected for definitive treatment and no specific rationale is recorded.

Service type: Antimicrobial stewardship / inpatient or outpatient therapeutic decision documentation

Typical site of service: Inpatient hospital or outpatient clinic settings where definitive antibiotic therapy decisions are documented, including infectious disease consults and antimicrobial stewardship program activities.

Data not available in the input.

Clinical Context

A patient hospitalized for a confirmed bacterial infection (for example, community-acquired pneumonia or complicated urinary tract infection) receives initial empiric therapy that includes a beta-lactam antibiotic. During inpatient stay or at time of definitive therapy selection, the treating team documents that the patient is not being continued on a beta-lactam antibiotic as definitive therapy, but no reason for withholding the beta-lactam is recorded. Typical workflow: patient admitted to hospital or treated in an observation unit; cultures and susceptibilities are obtained; empiric antibiotics are started; antimicrobial stewardship or the primary team reviews culture data and selects definitive therapy; billing staff capture quality-reporting code G9560 when definitive therapy is not a beta-lactam and the medical record lacks a documented reason for not using a beta-lactam.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when documentation supports substantially greater work or complexity related to the patient encounter.
`23`	Unusual anesthesia

Taxonomy Code	Specialty	Notes
`207P00000X`	Internal Medicine	Inpatient physicians who manage antibiotic selection and definitive therapy.
`207Q00000X`	Infectious Disease	Specialists who advise on antimicrobial choice and stewardship.
`208000000X`	Family Medicine	Hospitalists or primary care physicians providing inpatient care and antibiotic management.
`363A00000X`	Clinical Pharmacist	Antimicrobial stewardship pharmacists who recommend definitive therapy adjustments.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J18.9`	Pneumonia, unspecified organism	Common infection where beta-lactam antibiotics are often definitive therapy; documentation may reflect alternative choices.
`N39.0`	Urinary tract infection, site not specified	Frequent indication for antibiotics where beta-lactams may be considered but sometimes alternatives are used.
`A41.9`	Sepsis, unspecified organism	Severe systemic infection prompting empiric broad-spectrum therapy and later definitive selection.
`K75.0`	Acute hepatic failure	Represents conditions that may contraindicate certain beta-lactams or require alternative agents.
`R65.21`	Severe sepsis with septic shock	Critical illness where definitive antibiotic choice is essential and documentation of rationale is required.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99221`	Initial hospital care, per day, typically 30 minutes	Admission evaluation where empiric antibiotics are begun and initial therapy decisions are documented.
`99231`	Subsequent hospital care, per day, typically 15 minutes	Daily management visits where definitive therapy selection and documentation occur.
`87086`	Culture, bacterial, blood, quantitative colony count not performed; blood cultures (per date) — Note: this is CPT Category II/III equivalent laboratory service description	Microbiology testing used to guide definitive antibiotic choice.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify drug); subcutaneous or intramuscular	Administration of parenteral antibiotics given while definitive therapy decisions are made.
`G0008`	Administration of influenza virus vaccine (for example) — (example preventive service)	Not directly related clinically but listed here to indicate common preventive services documented during hospital stays; included when vaccination is given during admission.

OpenPayer

Summary & Overview

HCPCS G9560: Patient Not Treated with Beta-Lactam as Definitive Therapy